Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eun Yoon Cho

Showing results (141-150 of 159) with videos related to

Pageof 16
Sort By:
Breast Cancer Research and Treatment|June 23, 2018
Validation of the new AJCC eighth edition of the TNM classification for breast cancer with a single-center breast cancer cohortJi-Yeon Kim, Ji Eun Lim, Hae Hyun Jung, et al.
BMC Cancer|September 24, 2010
Triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survivalYoon-La Choi, Ensel Oh, Sarah Park, et al.
Human Pathology|June 27, 2003
Detection of germinal center B-cell lymphoma in archival specimens: critical evaluation of Bcl-6 protein expression in diffuse large B-cell lymphoma of the tonsilHowe J Ree, Koichi Ohsima, Katsuyuki Aozasa, et al.
Breast Cancer Research and Treatment|December 4, 2009
A risk stratification by hormonal receptors (ER, PgR) and HER-2 status in small (< or = 1 cm) invasive breast cancer: who might be possible candidates for adjuvant treatment?Yeon Hee Park, Seung Tae Kim, Eun Yoon Cho, et al.
Cancer Research and Treatment|February 25, 2016
Association between Mutation and Expression of <i>TP53</i> as a Potential Prognostic Marker of Triple-Negative Breast CancerJi-Yeon Kim, Kyunghee Park, Hae Hyun Jung, et al.
Cell Reports. Medicine|June 7, 2025
Spatial and genomic profiling of residual breast cancer after neoadjuvant chemotherapy unveil divergent fates for each breast cancer subtypeEun Seop Seo, Sabin Park, Eun Yoon Cho, et al.
Oncology|June 7, 2014
Validation and comparison of CS-IHC4 scores with a nomogram to predict recurrence in hormone receptor-positive breast cancersYeon Hee Park, Seock-Ah Im, Eun Yoon Cho, et al.
Journal of Pathology and Translational Medicine|February 23, 2026
Prevalence of HER2-ultralow breast cancer in South Korea: a multicenter study by reassessment of HER2-zero casesMin Chong Kim, Eun Yoon Cho, Hee Jin Lee, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 15, 2025
Real-world evidence of the efficacy of neoadjuvant pembrolizumab in triple-negative breast cancer: A surgeon's point of viewWoong Ki Park, Seok Jin Nam, Seok Won Kim, et al.
Neuro-Oncology|June 14, 2012
Prediction of outcomes for patients with brain parenchymal metastases from breast cancer (BC): a new BC-specific prognostic model and a nomogramHee Kyung Ahn, Soohyeon Lee, Yeon Hee Park, et al.
Pageof 16

Showing results (141-150 of 159) with videos related to

Sort By:
Pageof 16
Breast Cancer Research and Treatment|June 23, 2018
Validation of the new AJCC eighth edition of the TNM classification for breast cancer with a single-center breast cancer cohortJi-Yeon Kim, Ji Eun Lim, Hae Hyun Jung, et al.
BMC Cancer|September 24, 2010
Triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survivalYoon-La Choi, Ensel Oh, Sarah Park, et al.
Human Pathology|June 27, 2003
Detection of germinal center B-cell lymphoma in archival specimens: critical evaluation of Bcl-6 protein expression in diffuse large B-cell lymphoma of the tonsilHowe J Ree, Koichi Ohsima, Katsuyuki Aozasa, et al.
Breast Cancer Research and Treatment|December 4, 2009
A risk stratification by hormonal receptors (ER, PgR) and HER-2 status in small (< or = 1 cm) invasive breast cancer: who might be possible candidates for adjuvant treatment?Yeon Hee Park, Seung Tae Kim, Eun Yoon Cho, et al.
Cancer Research and Treatment|February 25, 2016
Association between Mutation and Expression of <i>TP53</i> as a Potential Prognostic Marker of Triple-Negative Breast CancerJi-Yeon Kim, Kyunghee Park, Hae Hyun Jung, et al.
Cell Reports. Medicine|June 7, 2025
Spatial and genomic profiling of residual breast cancer after neoadjuvant chemotherapy unveil divergent fates for each breast cancer subtypeEun Seop Seo, Sabin Park, Eun Yoon Cho, et al.
Oncology|June 7, 2014
Validation and comparison of CS-IHC4 scores with a nomogram to predict recurrence in hormone receptor-positive breast cancersYeon Hee Park, Seock-Ah Im, Eun Yoon Cho, et al.
Journal of Pathology and Translational Medicine|February 23, 2026
Prevalence of HER2-ultralow breast cancer in South Korea: a multicenter study by reassessment of HER2-zero casesMin Chong Kim, Eun Yoon Cho, Hee Jin Lee, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 15, 2025
Real-world evidence of the efficacy of neoadjuvant pembrolizumab in triple-negative breast cancer: A surgeon's point of viewWoong Ki Park, Seok Jin Nam, Seok Won Kim, et al.
Neuro-Oncology|June 14, 2012
Prediction of outcomes for patients with brain parenchymal metastases from breast cancer (BC): a new BC-specific prognostic model and a nomogramHee Kyung Ahn, Soohyeon Lee, Yeon Hee Park, et al.
Pageof 16